New hope for myeloma patients: drug combo shows promise in early trial
NCT ID NCT05060627
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This study tests a new combination of three drugs (belantamab mafodotin, carfilzomib, and dexamethasone) in people whose multiple myeloma has returned and stopped responding to a previous treatment. The goal is to find the safest dose and see how well it controls the cancer. About 60 adults will take part in this early-phase trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clínica Universidad de Navarra (CUN)
Pamplona, Spain
-
Complejo Hospitalario Santiago (CHUS)
Santiago de Compostela, Spain
-
Complejo Hospitalario Virgen del Rocío
Seville, Spain
-
H. Gregorio Marañón
Madrid, Spain
-
H. Morales Meseguer
Murcia, Spain
-
H. Son Llatzer
Palma de Mallorca, Spain
-
H. Universitario Marqués de Valdecilla
Santander, Spain
-
H. Universitario de Canarias
Santa Cruz de Tenerife, Spain
-
H.U. La Fe
Valencia, Spain
-
HUCA
Oviedo, Spain
-
Hospital Clinic
Barcelona, Spain
-
Hospital Germans Trias i Pujol (ICO BADALONA)
Badalona, Spain
-
Hospital Universitario 12 de Octubre
Madrid, Spain
-
Hospital Universitario de Salamanca
Salamanca, Spain
-
ICO Duran i Reynals
L'Hospitalet de Llobregat, Spain
Conditions
Explore the condition pages connected to this study.